Skip to main content

and
  1. Article

    Open Access

    Fulminant myocarditis during postoperative adjuvant chemotherapy for lung cancer with atezolizumab: a case report

    Postoperative adjuvant systemic therapy with atezolizumab for lung cancer has been reported to be effective. Although myocarditis is a rare immune adverse event associated with atezolizumab, it can have a seri...

    Takuya Tokunaga, Masaya Aoki, Koki Maruyama, Yuto Nonaka in Journal of Medical Case Reports (2024)